Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-28 @ 1:37 PM
Study NCT ID:
NCT00374868
Status:
COMPLETED
Last Update Posted:
2010-11-04
First Post:
2006-09-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08
Start Date Type:
None
Primary Completion Date:
2008-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-04
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-11
First Submit QC Date:
None
Study First Post Date:
2006-09-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-04-29
Results First Submit QC Date:
None
Results First Post Date:
2009-06-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-10-20
Last Update Post Date:
2010-11-04
Last Update Post Date Type:
ESTIMATED